Home » Sodium Oxybate Will Have More Than 15 Percent of 2018 Fibromyalgia Market
Sodium Oxybate Will Have More Than 15 Percent of 2018 Fibromyalgia Market
Decision Resources … finds that, despite potential safety concerns, Jazz Pharmaceuticals/UCB’s sodium oxybate (JZP-6) will account for more than 15 percent of the fibromyalgia drug market in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Earth Times
Earth Times
Upcoming Events
-
07May
-
14May
-
30May